EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 168 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $101 | -66.1% | 6,414 | -58.1% | 0.00% | – |
| Q2 2023 | $298 | -38.3% | 15,319 | -10.1% | 0.00% | -100.0% |
| Q1 2023 | $483 | -37.8% | 17,041 | -35.8% | 0.00% | 0.0% |
| Q4 2022 | $776 | -99.7% | 26,564 | +216.6% | 0.00% | – |
| Q3 2022 | $222,000 | -40.3% | 8,390 | +0.2% | 0.00% | – |
| Q2 2022 | $372,000 | -10.6% | 8,377 | -0.3% | 0.00% | – |
| Q1 2022 | $416,000 | -2.8% | 8,405 | +0.1% | 0.00% | – |
| Q4 2021 | $428,000 | -8.9% | 8,398 | -0.4% | 0.00% | -100.0% |
| Q3 2021 | $470,000 | +3.8% | 8,430 | -20.4% | 0.00% | – |
| Q2 2021 | $453,000 | +3.4% | 10,584 | +0.8% | 0.00% | – |
| Q1 2021 | $438,000 | -18.9% | 10,500 | -9.5% | 0.00% | -100.0% |
| Q4 2020 | $540,000 | +9.5% | 11,600 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $493,000 | -11.5% | 11,600 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $557,000 | +27.5% | 11,600 | +22.1% | 0.00% | 0.0% |
| Q1 2020 | $437,000 | -23.5% | 9,500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $571,000 | +6.3% | 9,500 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $537,000 | -53.1% | 9,500 | -53.8% | 0.00% | 0.0% |
| Q2 2019 | $1,146,000 | +55.1% | 20,575 | +40.6% | 0.00% | 0.0% |
| Q1 2019 | $739,000 | +25.3% | 14,636 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $590,000 | -88.1% | 14,636 | -79.6% | 0.00% | -83.3% |
| Q3 2018 | $4,966,000 | +3.8% | 71,633 | +13.3% | 0.01% | 0.0% |
| Q2 2018 | $4,783,000 | +40.8% | 63,211 | -1.9% | 0.01% | +50.0% |
| Q1 2018 | $3,397,000 | +2.2% | 64,467 | +3.6% | 0.00% | 0.0% |
| Q4 2017 | $3,324,000 | +9.2% | 62,233 | +22.0% | 0.00% | 0.0% |
| Q3 2017 | $3,043,000 | -25.1% | 51,020 | -0.9% | 0.00% | -20.0% |
| Q2 2017 | $4,063,000 | +34.2% | 51,503 | +41.1% | 0.01% | +25.0% |
| Q1 2017 | $3,027,000 | +118.4% | 36,501 | +109.0% | 0.00% | +100.0% |
| Q4 2016 | $1,386,000 | +110.6% | 17,467 | +85.8% | 0.00% | +100.0% |
| Q3 2016 | $658,000 | +90.7% | 9,400 | +5.6% | 0.00% | 0.0% |
| Q2 2016 | $345,000 | -4.2% | 8,900 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $360,000 | -66.3% | 8,900 | -26.0% | 0.00% | -50.0% |
| Q4 2015 | $1,067,000 | +26.1% | 12,034 | +5.2% | 0.00% | +100.0% |
| Q3 2015 | $846,000 | +17.5% | 11,434 | +28.4% | 0.00% | 0.0% |
| Q2 2015 | $720,000 | +510.2% | 8,904 | +216.8% | 0.00% | – |
| Q1 2015 | $118,000 | – | 2,811 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 400,000 | $5,732,000 | 1.52% |
| Park West Asset Management LLC | 426,900 | $6,117,000 | 0.80% |
| WALL STREET ASSOCIATES | 200,000 | $2,866,000 | 0.25% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 284,653 | $4,079,000 | 0.16% |
| FARALLON CAPITAL MANAGEMENT LLC | 100,000 | $1,433,000 | 0.02% |
| NEXT Financial Group, Inc | 2,500 | $26,000 | 0.01% |
| PIPER SANDLER & CO. | 1,277 | $18,000 | 0.01% |
| Ground Swell Capital, LLC | 400 | $6,000 | 0.01% |
| PARADIGM ASSET MANAGEMENT CO LLC | 6,300 | $90,279,000 | 0.01% |
| Paloma Partners Management Co | 14,363 | $206,000 | 0.01% |